Clinical Trial Update: HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

View source ↗

Summary

A completed clinical trial update examining HIV-1 subtype-specific drug resistance in patients failing a dolutegravir-based regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: University of Bern | Conditions: Hiv | Status: COMPLETED